Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
about
Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotionGenetics and biology of pancreatic ductal adenocarcinomaNonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and MousePancreatic adenocarcinoma pathology: changing "landscape"Reserve stem cells: Differentiated cells reprogram to fuel repair, metaplasia, and neoplasia in the adult gastrointestinal tractMouse models of pancreatic cancerPancreatic ductal cells in development, regeneration, and neoplasiaHuman correlates of provocative questions in pancreatic pathologyA Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasUtilizing past and present mouse systems to engineer more relevant pancreatic cancer modelsFascin is regulated by slug, promotes progression of pancreatic cancer in mice, and is associated with patient outcomesA novel synthetic smoothened antagonist transiently inhibits pancreatic adenocarcinoma xenografts in a mouse modelMALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancerAnti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancerDevelopment and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinomaEvaluation of a gene-directed enzyme-product therapy (GDEPT) in human pancreatic tumor cells and their use as in vivo models for pancreatic cancerInhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancerPancreatic cancer.Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model.KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of originInactivation of TIF1gamma cooperates with Kras to induce cystic tumors of the pancreas.Phenethyl isothiocyanate inhibits proliferation and induces apoptosis in pancreatic cancer cells in vitro and in a MIAPaca2 xenograft animal model.RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia.Stromal reengineering to treat pancreas cancerRetinoid signaling in pancreatic cancer, injury and regeneration.PTEN loss accelerates KrasG12D-induced pancreatic cancer developmentCholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in miceAbsence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer.The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodelingSMYD3 links lysine methylation of MAP3K2 to Ras-driven cancerDetection of precursor lesions of pancreatic adenocarcinoma in PET-CT in a genetically engineered mouse model of pancreatic cancer.Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.Dimethylaminoparthenolide and gemcitabine: a survival study using a genetically engineered mouse model of pancreatic cancerThe epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse model.Precursor lesions of early onset pancreatic cancer.A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer.Update on pancreatic intraepithelial neoplasia.MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer
P2860
Q24644807-E1B83105-9CB4-4C71-841B-A92A1ADCCE76Q26765438-D42EFD5F-1540-40C9-8846-CA98F0CB2C99Q26766096-8258C886-5581-4A57-9800-B5EA9046F950Q26799446-C2D68106-51AD-4B08-B6D9-82F940211B49Q26801731-E8D3A57C-0D65-408E-92D2-9EE8F9F15E7DQ26860574-0164F860-0A5A-4159-A1BF-642D39D198D3Q27006729-CF35C252-0875-4A83-8874-525AADFF2F47Q27023576-05A161B2-9DA5-4C62-B6C9-0688147800D9Q28082890-DC523218-F194-4959-ACF1-2A0A9EB9CBB1Q28083091-C9264360-8FC3-4DEA-8195-1DBCBBCA975EQ28306591-A7778C31-C0D8-478D-8040-C9A0AE9CEEDBQ28478580-F81C1940-C11F-4FB0-912D-12229C9942FDQ28480625-7AB0897D-D38C-4107-BD9B-C7D4F079EC10Q28534413-D2E3AAD8-391C-4A46-8243-D2F939E448C0Q28534618-FC01DE10-874D-4B43-A6C9-E23274D78D1BQ28729144-2DC5C1DB-5F8C-49A9-AAD4-563A66A876B8Q29547558-538E43D0-399C-4410-9815-EC56989D3DA7Q30490247-410315E0-7270-4688-8542-8496D2641E34Q30498093-C104A4B2-31E7-4D05-B2A2-18FA52D5FE8BQ30513617-A1AECCF8-D3E0-4F8F-B56D-770BDF7D3975Q33408107-E23DCEA3-C578-4E32-A807-F3348362DD86Q33486497-6C6A16A4-47DC-4713-AE05-2DB804915425Q33560683-85081107-6F31-47F5-B9F5-10EE89240EA1Q33726461-049BF4D8-C210-43CA-88C2-02C9E8E274B1Q33754775-398C4E18-2CBF-4A3F-AEB7-2BAFF98F8735Q33827708-6E9B1394-CAEC-4AB0-BD8B-1AA5B3372BF4Q34119073-255CB914-A0F2-492A-80A6-17312A9E2E7EQ34134396-8BDDD699-70CF-4BF6-B257-95876982C50BQ34167464-344F366C-77AA-4F9D-9914-D1C56CD5555FQ34167517-D10BB42F-8CD3-4C75-9718-E503F4E503B2Q34283489-96009AD8-21CE-4B0F-A262-FBF091AC7221Q34420873-BD6FDD3A-25AF-40A2-8188-274B74523B13Q34551574-CA6541AF-1BF6-412B-AF87-6B78B23FEFE3Q34620985-70989EFB-19B4-4322-B195-B93BB23AA25DQ34670483-95D0EEC2-5C32-4E06-8D9C-D081D50DFE05Q34681112-1A5BDB64-B941-41DE-93CD-B3ECCDFE8151Q34705599-ACE70CB7-7E99-4495-87CB-8D164E38CFB7Q34729793-7244876B-6295-443D-8266-0D6420756A68Q34826200-EC2091CB-3A0B-483E-8126-732780C557D6Q35034874-778835EF-3B0A-4F6A-BE5C-9CE67A9921C4
P2860
Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Pathology of genetically engin ...... us report and recommendations.
@ast
Pathology of genetically engin ...... us report and recommendations.
@en
type
label
Pathology of genetically engin ...... us report and recommendations.
@ast
Pathology of genetically engin ...... us report and recommendations.
@en
prefLabel
Pathology of genetically engin ...... us report and recommendations.
@ast
Pathology of genetically engin ...... us report and recommendations.
@en
P2093
P50
P1433
P1476
Pathology of genetically engin ...... sus report and recommendations
@en
P2093
Alison Klein
Anirban Maitra
Daniel S Longnecker
David S Klimstra
Emma E Furth
G Johan A Offerhaus
Gregory P Boivin
Gregory Y Lauwers
Gunter Kloppel
Jorge Albores-Saavedra
P304
P356
10.1158/0008-5472.CAN-05-2168
P407
P577
2006-01-01T00:00:00Z